Vestar, Inc.

Company Information
Address 650 Cliffside Drive
San Dimas, CA, 91773


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Liposomal TNF¿Potential Application as Cancer Therapy

    Amount: $596,469.00

    Preliminary findings indicate that liposomal tumor necrosis factor (TNF) has potential application as an anti-tumor therapy. In initial studies, it retains cytotoxic activity against cancer cells in c ...

    SBIRPhase II1995Department of Health and Human Services
  2. Selectively Modified Tumor Necrosis Factor

    Amount: $50,000.00

    Genes for selectively modified tumor necrosis factor (SM-TNF) will be used to produce sufficient quantities of the proteins for testing. To accomplish this goal, the genes for TNF-alpha and TNF-beta w ...

    SBIRPhase I1993Department of Health and Human Services
  3. Liposomal TNF¿Potential Application as Cancer Therapy

    Amount: $50,000.00

    N/A

    SBIRPhase I1993Department of Health and Human Services
  4. LYOPHILIZATION OF LIPOSOME ENCAPSULATED HEMOGLOBIN

    Amount: $500,000.00

    VESTAR PROPOSES TO DEVELOP THE METHODS NECESSARY TO LYOPHILIZE LIPOSOME ENCAPSULATED HEMOGLOBIN (IEH) . THE METHODS AND EQUIPMENT UTILIZED WILL BE COMMENSURATE WITH LARGE-SCALE LYOPHILIZATION PRACTICE ...

    SBIRPhase II1991Navy Department of Defense
  5. IL-2 LIPOSOMES AS DELIVERY AGENTS FOR IMMUNOTHERAPEUTICS

    Amount: $47,838.00

    VESTAR HAS DEVELOPED A LIPOSOMAL DRUG DELIVERY SYSTEM COMPRISED OF (MTX) ENCAPSULATED IN THE INTERNAL AQUEOUS SPACE OF SMALL UNILAMELLAR VESICLES AND HUMAN RECOMBINANT IL-2 COVALENTLY COUPLED TO THE E ...

    SBIRPhase I1991Department of Health and Human Services
  6. LIPOSOMAL GOLD COMPOUNDS\IMPROVED ANTIARTHRITIC THERAPY

    Amount: $46,571.00

    CONJUGATED GOLD COMPOUNDS SUCH AS AUROTHIOMALATE, ARE ADMINISTERED IN PROGRESSIVE RHEUMATOID ARTHRITIS. AT PRESENT, ONLY THESE ANTIARTHRITICS ARREST THE PROGRESSION OF THE DISEASE. TREATMENT IS LIMITE ...

    SBIRPhase I1991Department of Health and Human Services
  7. LYOPHILIZATION OF LIPOSOME ENCAPSULATED HEMOGLOBIN

    Amount: $50,000.00

    N/A

    SBIRPhase I1991Navy Department of Defense
  8. IMMUNOLIPOSOME DELIVERY OF CHEMOTHERAPEUTICS

    Amount: $50,000.00

    THIS PROJECT WILL DEVELOP MONOCLONAL ANTIBODY-TARGETED LIPOSOMES FOR THE PURPOSE OF DELIVERING CHEMOTHERAPEUTIC AGENTS. MONOCLONAL ANTIBODY RAISED AGAINST A TUMOR-SPECIFICSURFACE ANTIGEN WILL BE COVAL ...

    SBIRPhase I1990Department of Health and Human Services
  9. LIPOSOME-ENCAPSULATED B-10 FOR NEUTRON CAPTURE THERAPY

    Amount: $50,000.00

    NEUTRON CAPTURE THERAPY IS AN ATTRACTIVE ALTERNATIVE TO STANDARD RADIATION TECHNIQUES FOR CANCER TREATMENT IF NUCLEI, SUCH AS (10)B, CAN BE SELECTIVELY CONCENTRATED IN TUMORS. SMALL, UNILAMELLAR, PHOS ...

    SBIRPhase I1987Department of Health and Human Services
  10. ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY.

    Amount: $50,000.00

    ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY. ONE THERAPEUTIC APPROACHTO THIS PROBLEM IS THE APPLICATION OF THROMBOLYTIC AGENTS, SUCH AS STREPTOKINASE, TO P ...

    SBIRPhase I1986Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government